You are here: Industry Insights > editing

News List

Molecular Editing in Drug Discovery: Making Peripheral and Skeletal Changes Suzanne Elvidge
April 01, 2025
Drug discovery often begins with high-throughput screening of large libraries to identify potential hits.
Gene Editing Destiny: The CRISPR Revolution and Beyond Shruti Talashi
August 01, 2024
Genome editing has the potential to eradicate hereditary illnesses, improve human potential, and transform biotechnology and agriculture with continued research and development.
Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template PharmaSources
May 10, 2024
Nucleic Acid Medicines Manufacture, Round 2 call.
Initial CRISPR Gene Editing Therapy has been Approved. What is the Domestic Progress? Yefenghong/PharmaSources
December 14, 2023
Vertex Pharmaceuticals and CRISPR Therapeutics announced that their jointly developed CRISPR gene editing therapy CASGEVY has been conditionally approved.
World First: CRISPR Gene Editing Approved in the UK David Orchard-Webb
December 01, 2023
The UK Medicines and Healthcare products Regulatory Agency granted conditional marketing approval for Vertex & CRISPR Therapeutics’ Casgevy to treat Sickle Cell Disease and transfusion-dependent beta thalassemia on November 16, 2023.
Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations PRNewswire
December 06, 2024
Qi Biodesign, a biotechnology company pioneering next-generation genome editing technologies, announced the completion of its Series A funding round.
Bayer and Mammoth Biosciences to collaborate on novel gene editing technolog WorldPharmaNews
January 11, 2022
Bayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity of nature to power the next-generation CRISPR products, today announced a strategic collaboration...
Electroporation Instruments Market to Expand at CAGR of 6.3% from 2020 to 2030; Growth in Popularity of Different Gene-editing Techniques to Drive Market Expansion, Says TMR prnewswire
November 11, 2021
Major companies operating in the electroporation instruments market are focused on advancing the performance and efficacy of products they offer.
Editas Medicine Presents Data on New SLEEK Gene Editing Technology at Cold Spring Harbor Laboratory’s Genome Engineering: CRISPR Frontiers Meeting firstwordpharma
August 23, 2021
Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced data on a new gene editing technologytermed SLEEK (SeLection by Essential-gene Exon Knock-in).
Gene editing company Prime Medicine launches with $315m funds pharmaceutical-technology
July 15, 2021
Prime Medicine has raised a total of $315m in Series A and B funding rounds to launch the company that will offer new gene-editing technology Prime Editing for developing cures for various diseases.